Clinical trials: Atrium; Beat
Atrium; Beat, Echocardiography
Chronic Ibrutinib Therapy Effect on Left Atrial Function
Ibrutinib is an irreversible Bruton tyrosine-kinase inhibitor. In prospective studies, the ibrutinib efficacy in the treatment of various B-cell malignancies was established.
- Conditions
- Atrium; Beat, Echocardiography, Physiology, Therapy Adverse Effect
- Trial name
- CITE-LA (NCT03751410)
- Where
- Croatia
- Volunteers
- 40 people
- Sponsor
- University Hospital Sestre Milosrdnice